Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Guillaume Jaisson"


2 mentions found


London CNN —The Magnificent 7 tech stocks have been a big part of the extraordinary US market rally. But there’s a rival group of companies powering European stocks to new heights with even better returns, by some measures. Dubbed the “Granolas,” those 11 companies accounted for 60% of the gains on Europe’s benchmark stock index over the past 12 months. They have even slightly outperformed the Magnificent 7 over a longer period, according to Goldman Sachs. Their standout performance has “raised the issue of concentration effects” in the region’s stock market, says Philip Lawlor, managing director of markets research at Wilshire Indexes.
Persons: London CNN —, Goldman Sachs, ASML, ” Goldman Sachs, Goldman Sachs, Guillaume Jaisson, Ozempic, , Philip Lawlor, ” Lawlor Organizations: London CNN, GSK, Roche, Novartis, Novo Nordisk, L’Oréal, AstraZeneca, SAP, Sanofi, , CNN, Danish, Wilshire Indexes, , Deutsche Bank Locations: LVMH, Europe, France, Germany, Denmark, Switzerland, Netherlands, United Kingdom, United States
Small-cap stocks are having a difficult time, even by this year's bear market standard. But Goldman Sachs ' Peter Oppenheimer believes the worst could be over for smaller companies, and names several stocks he likes within the space. "Small caps are down 34% year-to-date. Investors hoping for a respite in the fortunes of small caps could be in for a longer wait, however. Global stock picks While a turnaround in small caps may not be imminent, Oppenheimer believes the sector now looks "inexpensive."
Total: 2